A5088947938- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiac Imaging and Diagnostics
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Technology and Patient Monitoring
- Airway Management and Intubation Techniques
- Antibiotic Use and Resistance
- COVID-19 and healthcare impacts
- Cardiovascular and Diving-Related Complications
- Respiratory Support and Mechanisms
- Pneumonia and Respiratory Infections
- Ultrasound and Hyperthermia Applications
- Vascular Malformations and Hemangiomas
- Infection Control and Ventilation
- COVID-19 Clinical Research Studies
- Thermal Regulation in Medicine
- Cardiac Arrest and Resuscitation
- Venous Thromboembolism Diagnosis and Management
- Hemodynamic Monitoring and Therapy
- Gastroesophageal reflux and treatments
- Esophageal and GI Pathology
- Science Education and Pedagogy
- Cardiovascular Syncope and Autonomic Disorders
The University of Texas Southwestern Medical Center
2020-2024
New York State Department of Health
2024
Office of Science
2024
Addenbrooke's Hospital
2024
University of Cambridge
2024
Southwestern Medical Center
2022
East and North Hertfordshire NHS Trust
2021
Active esophageal cooling reduces the incidence of endoscopically identified severe lesions during radiofrequency (RF) catheter ablation left atrium for treatment atrial fibrillation. A formal analysis atrioesophageal fistula (AEF) rate with active has not previously been performed.
Abstract Background Active esophageal cooling during pulmonary vein isolation (PVI) with radiofrequency (RF) ablation for the treatment of atrial fibrillation (AF) is increasingly being utilized to reduce injury and atrioesophageal fistula formation. Randomized controlled data also show trends towards increased freedom from AF when using active cooling. This study aimed compare 1-year arrhythmia recurrence rates between patients treated luminal temperature (LET) monitoring versus left...
Active esophageal cooling is increasingly utilized as an alternative to luminal temperature (LET) monitoring for protection against thermal injury during pulmonary vein isolation (PVI) when treating atrial fibrillation (AF). Published data demonstrate the efficacy of active in reducing injury, but impacts on procedural efficiency are not well characterized. LET compels pauses ablation due heat stacking and overheating alarms that turn delay progress PVI procedure, whereas allows avoidance...
Background: There is currently a paucity of data describing bacterial coinfections, related antibiotic prescribing patterns, and the potential role antimicrobial stewardship in care patients infected with SARS-CoV-2. Methods: This prospective, observational study was conducted from March 10, 2020 to April 21, admitted confirmed COVID-19. Patients were included if ≥ 18 years old hospital for further treatment. Data collected via chart review enterprise electronic health record database....
Abstract Introduction Proactive esophageal cooling has been FDA cleared to reduce the likelihood of ablation‐related injury resulting from radiofrequency (RF) cardiac ablation procedures. Data suggest that procedure times for RF pulmonary vein isolation (PVI) also decrease when proactive is employed instead luminal temperature (LET) monitoring. Reduced may allow increased electrophysiology (EP) lab throughput. We aimed quantify change in EP throughput PVI cases after introduction cooling....
Abstract Background There is currently a paucity of data describing bacterial coinfections, related antibiotic prescribing patterns, and the potential role antimicrobial stewardship in care patients infected with SARS-CoV-2. Methods This prospective, observational study was conducted from March 10, 2020 to April 21, admitted confirmed COVID-19. Patients were included if ≥ 18 years old hospital for further treatment. Data collected via chart review enterprise electronic health record...
Esophageal thermal injury is one of the most feared risks ablation posterior left atrium despite various devices used to monitor esophageal temperature or deviate esophagus. Reactive cooling, in which cold water manually instilled into esophagus via an orogastric tube response rises luminal (LET), has been by operators, but availability a dedicated cooling device offers ability provide proactive without having react individual The objective this study was evaluate feasibility using...
Abstract Background Increased efficiency in procedure times may improve electrophysiology lab throughput and enhance patient care. The choice of esophageal protection method during pulmonary vein isolation (PVI) can affect procedural efficiency, with recent data suggesting that active cooling is associated shorter when compared luminal temperature (LET) monitoring. Objective To compare PVI before after the adoption a large multicenter analysis. Methods Procedural were obtained from 5...
Although specific temperature targets are debated, targeted management (TTM) is a common treatment for postcardiac arrest patients. However, consistently implementing TTM protocol challenging, especially in community hospital. Often, the protocols described literature include labor- and cost-intensive methods that not feasible or sustainable many health care settings. Esophageal (ETM) method can be easily utilized alone combined with surface methods. We sought to evaluate ETM cohort of...
Background Left atrial ablation to obtain pulmonary vein isolation (PVI) for the treatment of fibrillation (AF) is a technologically intensive procedure utilizing innovative and continually improving technology. Changes in technology utilized PVI can turn lead changes costs. Because proximity esophagus posterior wall left atrium, various technologies have been protect against thermal injury during ablation. The impact on hospital costs from utilization different esophageal protection has not...
Abstract Background Proactive esophageal cooling is increasingly being utilized, and now FDA cleared, to reduce the likelihood of ablation-related injury resulting from radiofrequency (RF) cardiac ablation atrial fibrillation (AF). One-year follow-up largest randomized controlled study, IMPACT trial, showed a trend towards improvement in long-term efficacy versus luminal temperature (LET) monitoring. With larger data sets available for analysis, we sought determine 1-year freedom arrhythmia...
The hybrid convergent procedure is approved to treat symptomatic patients with long-standing persistent atrial fibrillation (AF). Despite direct visualization during surgical ablation as well the use of luminal oesophageal temperature (LET) monitoring, injury still possible. A dedicated device for proactive cooling has recently been cleared by Food and Drug Administration reduce likelihood ablation-related resulting from radiofrequency cardiac procedures. This report describes first uses...
Abstract Funding Acknowledgements Type of funding sources: None. Background As the burden atrial fibrillation continues to rise with an aging population, there have been contrasting positions on efficacy left ablation. While ablation techniques continued improve over past decades, arrhythmia recurrence rates must be further reduced given patients. Since continuity lesion sets has associated greater durability, it theorized that use active esophageal cooling may facilitate freedom from...
Various methods are utilized during radiofrequency (RF) pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF) to protect esophagus from inadvertent thermal injury. Active esophageal cooling is increasingly being used over traditional luminal temperature (LET) monitoring, and each approach may influence procedure times variability around those times. The objective this study measure effects on time in two different protection strategies utilizing advanced informatics...
ABSTRACT Background Active esophageal cooling reduces the incidence of endoscopically identified severe lesions during radiofrequency (RF) catheter ablation left atrium for treatment atrial fibrillation. No atrioesophageal fistula (AEF) has been reported to date with active cooling, and only one pericardio-esophageal reported; however, a formal analysis AEF rate not previously performed. Methods Atrial fibrillation procedure volumes before after adoption using dedicated device (ensoETM,...
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main source(s): Heart, Lung, And Blood Institute the Institutes Health. Background During left atrial ablation, lesions may be placed on posterior wall atrium. Due to anatomical proximity atrium esophagus, there is significant risk for thermal esophageal injury and potentially atrio-esophageal fistula. Ablation persistent fibrillation (AF) involve even more lesion placement, increased procedure...
Abstract Background Active esophageal cooling is a common method of protection during radiofrequency (RF) ablation for the treatment atrial fibrillation (AF). Compared to main alternative, luminal temperature (LET) monitoring, active reduces injury. Recent findings in community hospital setting indicate that procedure time and post-ablation chest pain may also be reduced, leading greater same-day patient discharge. Objective We aimed compare differences discharge rates patient-reported...
Introduction: Atrio-esophageal fistulas (AEF) are a feared and fatal complication of left atrial ablation for the treatment fibrillation (AF). The recent POTTER-AF survey suggests that AEFs continue to occur despite best efforts prevent them. A quantification incidence rates outcomes AEF reported Manufacturer User Facility Device Experience (MAUDE) database U.S. FDA may further elucidate trends in this complication. Research Question(s): What reporting AEF, what outcomes? Purpose: To...
The hybrid Convergent procedure is approved to treat symptomatic patients with long-standing persistent atrial fibrillation (AF). Despite direct visualization during surgical ablation as well the use of luminal esophageal temperature (LET) monitoring, injury still possible. A dedicated device for proactive cooling has recently been cleared by Food and Drug Administration (FDA) reduce likelihood ablation-related resulting from radiofrequency cardiac procedures. In this report, we describe...
Introduction : Proactive esophageal cooling has been FDA cleared to reduce the likelihood of ablation-related injury resulting from radiofrequency (RF) cardiac ablation procedures. Data suggest that procedure times for RF pulmonary vein isolation (PVI) also decrease when proactive is employed instead luminal temperature (LET) monitoring. Reduced may allow increased electrophysiology (EP) lab throughput. We aimed quantify change in EP throughput PVI cases after introduction cooling. Methods...